Acquisitions (Tables)

9 Months Ended

Sep. 30, 2013

Purchase Price Consideration Based on Common Stock and Cash Consideration

Based on the closing price of Alphatec’s common stock of $1.69 per share on November 6, 2012, cash consideration and contingent liabilities, the total purchase price for Phygen was as follows (in thousands):



Fair value of Alphatec common stock issued upon closing	$	8,856
Cash consideration paid and payable	5,900
Contingent consideration	3,724
Total purchase price	$	18,480

Allocation of Purchase Price and Estimated Useful Life of Assets Acquired

The following table summarizes the allocation of the purchase price of Phygen and the estimated useful lives for the acquired intangible assets (in thousands):



	Useful lives (in years)	Estimated Fair Value
Net tangible assets assumed		$	1,086
Acquired intangibles:
Developed technology	3	176
Trademarks	3	59
Covenant not-to-compete	3	389
Customer-related intangibles	12	5,843
Distribution network	12	2,413
Goodwill		8,514
Total purchase price allocation		$	18,480